US Stock MarketDetailed Quotes

BOLT Bolt Biotherapeutics

Watchlist

0.600
+0.021+3.70%

Close Nov 25 16:00 ET

0.570
-0.030-4.95%

Post 19:54 ET

22.96MMarket Cap-350P/E (TTM)

Bolt Biotherapeutics Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual

YOY

Hide blank lines

(Q3)Sep 30, 2024

(Q2)Jun 30, 2024

(Q1)Mar 31, 2024

(FY)Dec 31, 2023

(Q4)Dec 31, 2023

(Q3)Sep 30, 2023

(Q2)Jun 30, 2023

(Q1)Mar 31, 2023

(FY)Dec 31, 2022

(Q4)Dec 31, 2022

Total revenue

-54.87%1.14M

-11.03%1.28M

188.83%5.27M

37.48%7.88M

48.05%2.09M

19.70%2.53M

2.87%1.43M

124.60%1.83M

354.68%5.73M

177.76%1.41M

Operating revenue

-54.87%1.14M

-11.03%1.28M

188.83%5.27M

37.48%7.88M

48.05%2.09M

19.70%2.53M

2.87%1.43M

124.60%1.83M

354.68%5.73M

177.76%1.41M

Cost of revenue

Gross profit

Operating expense

-15.10%17.58M

-4.51%20.31M

10.50%22.37M

-12.47%84.07M

-2.65%21.86M

-15.32%20.71M

-13.03%21.27M

-18.02%20.24M

2.13%96.05M

-18.61%22.45M

Selling and administrative expenses

-34.05%3.8M

-13.29%4.87M

3.94%5.84M

-1.73%22.53M

-1.30%5.53M

5.01%5.76M

1.61%5.62M

-10.91%5.62M

24.65%22.93M

9.94%5.61M

-General and administrative expense

-34.05%3.8M

-13.29%4.87M

3.94%5.84M

-1.73%22.53M

-1.30%5.53M

5.01%5.76M

1.61%5.62M

-10.91%5.62M

24.65%22.93M

9.94%5.61M

Research and development costs

-7.80%13.79M

-1.35%15.43M

13.02%16.53M

-15.84%61.54M

-3.10%16.32M

-21.20%14.95M

-17.32%15.64M

-20.45%14.63M

-3.35%73.12M

-25.08%16.85M

Operating profit

9.57%-16.44M

4.03%-19.03M

7.18%-17.09M

15.64%-76.2M

6.06%-19.77M

18.63%-18.18M

13.99%-19.83M

22.87%-18.42M

2.66%-90.32M

22.29%-21.04M

Net non-operating interest income expense

-34.22%1.27M

-21.01%1.4M

11.92%1.61M

214.84%7M

78.62%1.86M

228.11%1.93M

349.37%1.78M

624.75%1.44M

691.10%2.22M

1,371.95%1.04M

Non-operating interest income

-34.22%1.27M

-21.01%1.4M

11.92%1.61M

214.84%7M

78.62%1.86M

228.11%1.93M

349.37%1.78M

624.75%1.44M

691.10%2.22M

1,371.95%1.04M

Other net income (expense)

-3.57M

4.68M

Special income (charges)

--0

---3.57M

----

--0

----

-Less：Restructuring and merger&acquisition

--0

--3.57M

----

--0

----

Other non- operating income (expenses)

----

--4.68M

----

Income before tax

6.65%-15.18M

-17.38%-21.2M

36.33%-10.81M

21.45%-69.2M

10.47%-17.9M

25.29%-16.26M

20.33%-18.06M

28.29%-16.98M

10.64%-88.1M

26.37%-20M

Income tax

Net income

6.65%-15.18M

-17.38%-21.2M

36.33%-10.81M

21.45%-69.2M

10.47%-17.9M

25.29%-16.26M

20.33%-18.06M

28.29%-16.98M

10.64%-88.1M

26.37%-20M

Net income continuous Operations

6.65%-15.18M

-17.38%-21.2M

36.33%-10.81M

21.45%-69.2M

10.47%-17.9M

25.29%-16.26M

20.33%-18.06M

28.29%-16.98M

10.64%-88.1M

26.37%-20M

Minority interest income

Net income attributable to the parent company

6.65%-15.18M

-17.38%-21.2M

36.33%-10.81M

21.45%-69.2M

10.47%-17.9M

25.29%-16.26M

20.33%-18.06M

28.29%-16.98M

10.64%-88.1M

26.37%-20M

Preferred stock dividends

Other preferred stock dividends

Net income attributable to common stockholders

6.65%-15.18M

-17.38%-21.2M

36.33%-10.81M

21.45%-69.2M

10.47%-17.9M

25.29%-16.26M

20.33%-18.06M

28.29%-16.98M

10.64%-88.1M

26.37%-20M

Basic earnings per share

6.98%-0.4

-16.67%-0.56

37.78%-0.28

22.46%-1.83

11.32%-0.47

25.86%-0.43

21.31%-0.48

29.69%-0.45

20.54%-2.36

27.40%-0.53

Diluted earnings per share

6.98%-0.4

-16.67%-0.56

37.78%-0.28

22.46%-1.83

11.32%-0.47

25.86%-0.43

21.31%-0.48

29.69%-0.45

20.54%-2.36

27.40%-0.53

Dividend per share

Currency Unit

USD

Accounting Standards

US-GAAP

Audit Opinions

Unqualified Opinion

	(Q3)Sep 30, 2024	(Q2)Jun 30, 2024	(Q1)Mar 31, 2024	(FY)Dec 31, 2023	(Q4)Dec 31, 2023	(Q3)Sep 30, 2023	(Q2)Jun 30, 2023	(Q1)Mar 31, 2023	(FY)Dec 31, 2022	(Q4)Dec 31, 2022
Total revenue	-54.87%1.14M	-11.03%1.28M	188.83%5.27M	37.48%7.88M	48.05%2.09M	19.70%2.53M	2.87%1.43M	124.60%1.83M	354.68%5.73M	177.76%1.41M
Operating revenue	-54.87%1.14M	-11.03%1.28M	188.83%5.27M	37.48%7.88M	48.05%2.09M	19.70%2.53M	2.87%1.43M	124.60%1.83M	354.68%5.73M	177.76%1.41M
Cost of revenue
Gross profit
Operating expense	-15.10%17.58M	-4.51%20.31M	10.50%22.37M	-12.47%84.07M	-2.65%21.86M	-15.32%20.71M	-13.03%21.27M	-18.02%20.24M	2.13%96.05M	-18.61%22.45M
Selling and administrative expenses	-34.05%3.8M	-13.29%4.87M	3.94%5.84M	-1.73%22.53M	-1.30%5.53M	5.01%5.76M	1.61%5.62M	-10.91%5.62M	24.65%22.93M	9.94%5.61M
-General and administrative expense	-34.05%3.8M	-13.29%4.87M	3.94%5.84M	-1.73%22.53M	-1.30%5.53M	5.01%5.76M	1.61%5.62M	-10.91%5.62M	24.65%22.93M	9.94%5.61M
Research and development costs	-7.80%13.79M	-1.35%15.43M	13.02%16.53M	-15.84%61.54M	-3.10%16.32M	-21.20%14.95M	-17.32%15.64M	-20.45%14.63M	-3.35%73.12M	-25.08%16.85M
Operating profit	9.57%-16.44M	4.03%-19.03M	7.18%-17.09M	15.64%-76.2M	6.06%-19.77M	18.63%-18.18M	13.99%-19.83M	22.87%-18.42M	2.66%-90.32M	22.29%-21.04M
Net non-operating interest income expense	-34.22%1.27M	-21.01%1.4M	11.92%1.61M	214.84%7M	78.62%1.86M	228.11%1.93M	349.37%1.78M	624.75%1.44M	691.10%2.22M	1,371.95%1.04M
Non-operating interest income	-34.22%1.27M	-21.01%1.4M	11.92%1.61M	214.84%7M	78.62%1.86M	228.11%1.93M	349.37%1.78M	624.75%1.44M	691.10%2.22M	1,371.95%1.04M
Other net income (expense)		-3.57M	4.68M
Special income (charges)	--0	---3.57M	----	----	----	--0	--0	----	----	----
-Less：Restructuring and merger&acquisition	--0	--3.57M	----	----	----	--0	--0	----	----	----
Other non- operating income (expenses)	----	----	--4.68M	----	----	----	----	----	----	----
Income before tax	6.65%-15.18M	-17.38%-21.2M	36.33%-10.81M	21.45%-69.2M	10.47%-17.9M	25.29%-16.26M	20.33%-18.06M	28.29%-16.98M	10.64%-88.1M	26.37%-20M
Income tax
Net income	6.65%-15.18M	-17.38%-21.2M	36.33%-10.81M	21.45%-69.2M	10.47%-17.9M	25.29%-16.26M	20.33%-18.06M	28.29%-16.98M	10.64%-88.1M	26.37%-20M
Net income continuous Operations	6.65%-15.18M	-17.38%-21.2M	36.33%-10.81M	21.45%-69.2M	10.47%-17.9M	25.29%-16.26M	20.33%-18.06M	28.29%-16.98M	10.64%-88.1M	26.37%-20M
Minority interest income
Net income attributable to the parent company	6.65%-15.18M	-17.38%-21.2M	36.33%-10.81M	21.45%-69.2M	10.47%-17.9M	25.29%-16.26M	20.33%-18.06M	28.29%-16.98M	10.64%-88.1M	26.37%-20M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders	6.65%-15.18M	-17.38%-21.2M	36.33%-10.81M	21.45%-69.2M	10.47%-17.9M	25.29%-16.26M	20.33%-18.06M	28.29%-16.98M	10.64%-88.1M	26.37%-20M
Basic earnings per share	6.98%-0.4	-16.67%-0.56	37.78%-0.28	22.46%-1.83	11.32%-0.47	25.86%-0.43	21.31%-0.48	29.69%-0.45	20.54%-2.36	27.40%-0.53
Diluted earnings per share	6.98%-0.4	-16.67%-0.56	37.78%-0.28	22.46%-1.83	11.32%-0.47	25.86%-0.43	21.31%-0.48	29.69%-0.45	20.54%-2.36	27.40%-0.53
Dividend per share
Currency Unit	USD	USD	USD	USD	USD	USD	USD	USD	USD	USD
Accounting Standards	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP
Audit Opinions	--	--	--	Unqualified Opinion	--	--	--	--	Unqualified Opinion	--

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List

Overall

No Data